D.E. Shaw & Co’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-41,360
| Closed | -$530K | – | 3124 |
|
|
2023
Q4 | $530K | Sell |
41,360
-115,057
| -74% | -$1.48M | ﹤0.01% | 2343 |
|
|
2023
Q3 | $5.79M | Sell |
156,417
-17,556
| -10% | -$650K | 0.01% | 1107 |
|
|
2023
Q2 | $7M | Buy |
173,973
+4,781
| +3% | +$192K | 0.01% | 1088 |
|
|
2023
Q1 | $12.3M | Buy |
169,192
+27,912
| +20% | +$2.02M | 0.01% | 816 |
|
|
2022
Q4 | $11.6M | Buy |
141,280
+32,484
| +30% | +$2.66M | 0.01% | 891 |
|
|
2022
Q3 | $10.3M | Buy |
108,796
+82,068
| +307% | +$7.76M | 0.01% | 885 |
|
|
2022
Q2 | $5.21M | Buy |
26,728
+210
| +0.8% | +$40.9K | 0.01% | 1517 |
|
|
2022
Q1 | $6.16M | Sell |
26,518
-10,258
| -28% | -$2.38M | 0.01% | 1494 |
|
|
2021
Q4 | $14.5M | Buy |
36,776
+3,500
| +11% | +$1.38M | 0.01% | 888 |
|
|
2021
Q3 | $14.9M | Buy |
33,276
+535
| +2% | +$239K | 0.01% | 821 |
|
|
2021
Q2 | $12.7M | Buy |
32,741
+5,419
| +20% | +$2.11M | 0.01% | 929 |
|
|
2021
Q1 | $9.81M | Buy |
27,322
+2,936
| +12% | +$1.05M | 0.01% | 1017 |
|
|
2020
Q4 | $12M | Buy |
24,386
+11,590
| +91% | +$5.69M | 0.01% | 905 |
|
|
2020
Q3 | $4.15M | Buy |
12,796
+916
| +8% | +$297K | ﹤0.01% | 1292 |
|
|
2020
Q2 | $4.33M | Buy |
+11,880
| New | +$4.33M | 0.01% | 1235 |
|
|
2018
Q3 | – | Sell |
-358
| Closed | -$329K | – | 2517 |
|
|
2018
Q2 | $329K | Sell |
358
-372
| -51% | -$342K | ﹤0.01% | 2293 |
|
|
2018
Q1 | $711K | Buy |
+730
| New | +$711K | ﹤0.01% | 1953 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 2542 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2607 |
|